Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
4.510
+0.070 (1.58%)
At close: Aug 24, 2026, 4:00 PM EDT
4.510
0.00 (0.00%)
After-hours: Aug 24, 2026, 4:10 PM EDT
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $14.51 million as of August 24, 2026. Its market cap has decreased by -39.45% in one year.
Market Cap
14.51M
Enterprise Value
-9.64M
1-Year Change
-39.45%
Ranking
Category
Stock Price
$4.51
ChartMarket Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $14.51M, a decrease of -98.48%. That is a compound annual growth rate of -47.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 14.51M | -61.31% |
| Dec 31, 2025 | 37.51M | 7.08% |
| Dec 31, 2024 | 35.03M | -36.74% |
| Dec 29, 2023 | 55.37M | -26.45% |
| Dec 30, 2022 | 75.28M | -78.09% |
| Dec 31, 2021 | 343.58M | -70.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chemomab Therapeutics | 15.65M |
| BioCardia | 15.29M |
| Akari Therapeutics, | 15.28M |
| SeaStar Medical Holding | 14.76M |
| BioVie | 14.71M |
| Moolec Science | 14.56M |
| BioLineRx | 14.03M |
| Lisata Therapeutics | 13.97M |